BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24438064)

  • 1. Time to begin adjuvant chemotherapy and survival in breast cancer patients: a retrospective observational study using latent class analysis.
    Downing A; Twelves C; Forman D; Lawrence G; Gilthorpe MS
    Breast J; 2014; 20(1):29-36. PubMed ID: 24438064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
    Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
    Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).
    Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A
    Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
    Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
    Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
    Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
    J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of breast cancer during pregnancy: an observational study.
    Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
    Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Goodwin JS
    J Clin Oncol; 2006 Jun; 24(18):2750-6. PubMed ID: 16782915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waiting times for radiotherapy after breast-conserving surgery and the association with survival: a path analysis.
    Downing A; Gilthorpe MS; Dodwell D; Lawrence G; Forman D
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):442-8. PubMed ID: 21377846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
    Lohrisch C; Paltiel C; Gelmon K; Speers C; Taylor S; Barnett J; Olivotto IA
    J Clin Oncol; 2006 Oct; 24(30):4888-94. PubMed ID: 17015884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.
    Chavez-MacGregor M; Clarke CA; Lichtensztajn DY; Giordano SH
    JAMA Oncol; 2016 Mar; 2(3):322-9. PubMed ID: 26659132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional disparities in breast cancer outcomes and the process of care.
    Weber JJ; Kachare SD; Vohra NA; Fitzgerald TF; Wong JH
    Am Surg; 2014 Jul; 80(7):669-74. PubMed ID: 24987898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
    J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.